Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Blood|January 15, 2008
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaKenneth I Ataga, Wally R Smith, Laura M De Castro, et al.
Plos One|September 27, 2016
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell AnemiaKenneth I Ataga, Vimal K Derebail, Melissa Caughey, et al.
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Haematologica|November 12, 2020
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Vimal K Derebail, et al.
Pediatric Blood & Cancer|February 8, 2018
Nephrin as a biomarker of sickle cell glomerulopathy in MalawiJ Brett Heimlich, Godwin Chipoka, Laila Elsherif, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
Annals of Plastic Surgery|May 21, 2025
Plastic Surgery in the Context of Shifting Federal Funding Priorities: An Analysis of Residency Position TrendsAnitesh Bajaj, Gabrielle C Rodriguez, Jason Zhang, et al.
Ejhaem|February 26, 2024
Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell diseaseMatthew Rees, Holly Spraker-Perlman, Raechyl Moore, et al.
International Journal of Public Health|August 2, 2021
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central MalawiGerald Tegha, Hillary M Topazian, Portia Kamthunzi, et al.
American Journal of Hematology|July 6, 2013
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Marvin E Reid, Adlette Inati, et al.
Pageof 15